RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq:SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the following virtual investor conferences.
Science 37® to Participate in Upcoming Investor Conferences
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here